×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [11]
山东大学 [5]
四川大学 [4]
吉林大学白求恩第一医... [3]
西安交通大学 [2]
中南大学 [2]
更多...
内容类型
期刊论文 [32]
发表日期
2018 [10]
2017 [3]
2016 [4]
2015 [2]
2014 [3]
2013 [4]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共32条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
期刊论文
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 卷号: 11
作者:
Zhao, Wan-Hong
;
Liu, Jie
;
Wang, Bai-Yan
;
Chen, Yin-Xia
;
Cao, Xing-Mei
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/11/26
BCMA
Refractory
Relapsed
CAR T
Multiple myeloma
Chimeric antigen receptor
Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial
期刊论文
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 卷号: Vol.20 No.6, 页码: 768-774
作者:
Zhou, K.
;
Wen, F.
;
Zhang, P.
;
Zhou, J.
;
Zheng, H.
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2019/02/28
Cost-effectiveness
Sensitive
relapsed
smallcell
lung
cancer
Cisplatin
plus
etoposide
plus
irinotecan
Topotecan
Second-line
chemotherapy
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: a meta-analysis
期刊论文
BMC CANCER, 2018, 卷号: Vol.18
作者:
Zhou, Hui
;
Luo, Yuling
;
Zhu, Sha
;
Wang, Xi
;
Zhao, Yunuo
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/02/28
Chimeric
antigen
receptor
T
(CAR
T)
therapy
Safety
Efficacy
Relapsed
or
refractory
B-cell
malignancies
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia.
期刊论文
International journal of hematologic oncology, 2018, 卷号: No.2, 页码: IJH06
作者:
Ma Jun
;
Liu Ting
;
Jin Jie
;
Hu Jianda
;
Liu Qifa
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/02/28
ALL
China
Philadelphia
chromosome-negative
B-cell
precursor
acute
lymphoblastic
leukemia
acute
lymphoblastic
leukemia
chemotherapy
relapsed/refractory
retrospective
observational
study
Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
期刊论文
CANCER MANAGEMENT AND RESEARCH, 2018, 卷号: 10
作者:
Luo, Xian-Wu
;
Du, Xue-Qing
;
Li, Jie-Li
;
Liu, Xiao-Ping
;
Meng, Xiang-Yu
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/05
multiple myeloma
refractory/relapsed
treatment regimens
efficacy
network meta-analysis
Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimen
期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: Vol.11, 页码: 7555-7558
作者:
Xiao, XiaoFang
;
Ye, XingNong
;
Xu, Cheng
;
Huang, Jian
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/26
relapsed
acute
lymphoblastic
leukemia
DC-CIK
rituximab
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia
期刊论文
2018, 卷号: 7, 期号: 2, 页码: IJH06
作者:
Ma Jun
;
Liu Ting
;
Jin Jie
;
Hu Jianda
;
Liu Qifa
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
ALL
China
Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia
acute lymphoblastic leukemia
chemotherapy
relapsed/refractory
retrospective observational study
Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning
期刊论文
2018, 卷号: 9, 期号: 1, 页码: 524-538
作者:
Guo, Zhi
;
Xu, Chen
;
Chen, Hu
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2020/01/03
reduce intensity
allogeneic hematopoietic stem cell transplantation
ETO positive
acute myeloid leukemia
relapsed
Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus
期刊论文
2018, 卷号: 97, 期号: 11, 页码: 2047-2054
作者:
Long, Zhangbiao
;
Yu, Fan
;
Du, Yali
;
Li, Hongmin
;
Chen, Miao
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/01/03
Acquired pure red cell aplasia
Refractory
relapsed
Cyclosporine A
Sirolimus
Regulatory T cells
Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, DoubleBlind Phase 2 Trial
期刊论文
2018, 卷号: 13, 期号: 10, 页码: S351-S352
作者:
Cheng, Y.
;
Wang, Q.
;
Li, K.
;
Shi, J.
;
Wu, L.
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Anlotinib
3rd line
relapsed SCLC
©版权所有 ©2017 CSpace - Powered by
CSpace